Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14217 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Kevin Aguilar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. Hauptthemen laut MEDLINE: Oxidative Stress, Mitochondrial Diseases, Neuroinflammatory Diseases, Energy Metabolism. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: Institutional funding from MINECO through the Centres of Excellence Severo Ochoa Award, CERCA Programme of the Generalitat de Catalunya, Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN.
Abstract (Originalsprache)
Objectives and scope Primary mitochondrial diseases (PMDs) are rare genetic disorders resulting from mutations in genes crucial for effective oxidative phosphorylation (OXPHOS) that can affect mitochondrial function. In this review, we examine the bioenergetic alterations and oxidative stress observed in cellular models of primary mitochondrial diseases (PMDs), shedding light on the intricate complexity between mitochondrial dysfunction and cellular pathology. We explore the diverse cellular models utilized to study PMDs, including patient‐derived fibroblasts, induced pluripotent stem cells (iPSCs) and cybrids. Moreover, we also emphasize the connection between oxidative stress and neuroinflammation. Insights The central nervous system (CNS) is particularly vulnerable to mitochondrial dysfunction due to its dependence on aerobic metabolism and the correct functioning of OXPHOS. Similar to other neurodegenerative diseases affecting the CNS, individuals with PMDs exhibit several neuroinflammatory hallmarks alongside neurodegeneration, a pattern also extensively observed in mouse models of mitochondrial diseases. Based on histopathological analysis of postmortem human brain tissue and findings in mouse models of PMDs, we posit that neuroinflammation is not merely a consequence of neurodegeneration but a potential pathogenic mechanism for disease progression that deserves further investigation. This recognition may pave the way for novel therapeutic strategies for this group of devastating diseases that currently lack effective treatments. Summary In summary, this review provides a comprehensive overview of bioenergetic alterations and redox imbalance in cellular models of PMDs while underscoring the significance of neuroinflammation as a potential driver in disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.
- Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology PAS, Warsaw, Poland.
- Departament de Bioquímica i Biomedicina Molecular, Universitat de Barcelona, Barcelona, Spain.
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
ORCID-Profile: Patrycja Jakubek, Mariusz R Wieckowski
Förderung
- Institutional funding from MINECO through the Centres of Excellence Severo Ochoa Award
- CERCA Programme of the Generalitat de Catalunya
- Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN
- Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan
- CIBERDEM ("Instituto de Salud Carlos III")
- AFM Téléthon
- MICINN
- Fundació Marató de TV3
Zitieren
APA
Aguilar, K., Jakubek, P., Zorzano, A., & Wieckowski, M. R. (2024). Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14217
Vancouver
Aguilar K, Jakubek P, Zorzano A, Wieckowski MR. Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14217
BibTeX
@article{Aguilar2024,
author = {Aguilar, Kevin and Jakubek, Patrycja and Zorzano, Antonio and Wieckowski, Mariusz R},
title = {Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14217}
}
EUVIMED